DK0876362T3 - Nye taxoider, deres fremstilling og farmaceutiske præparater deraf - Google Patents

Nye taxoider, deres fremstilling og farmaceutiske præparater deraf

Info

Publication number
DK0876362T3
DK0876362T3 DK96942433T DK96942433T DK0876362T3 DK 0876362 T3 DK0876362 T3 DK 0876362T3 DK 96942433 T DK96942433 T DK 96942433T DK 96942433 T DK96942433 T DK 96942433T DK 0876362 T3 DK0876362 T3 DK 0876362T3
Authority
DK
Denmark
Prior art keywords
preparation
pharmaceutical compositions
new taxoids
taxoids
new
Prior art date
Application number
DK96942433T
Other languages
Danish (da)
English (en)
Inventor
Alain Commercon
Herve Bouchard
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0876362T3 publication Critical patent/DK0876362T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK96942433T 1995-12-22 1996-12-19 Nye taxoider, deres fremstilling og farmaceutiske præparater deraf DK0876362T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9515379A FR2742751B1 (fr) 1995-12-22 1995-12-22 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR1996/002031 WO1997023473A1 (fr) 1995-12-22 1996-12-19 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK0876362T3 true DK0876362T3 (da) 2004-02-02

Family

ID=9485871

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96942433T DK0876362T3 (da) 1995-12-22 1996-12-19 Nye taxoider, deres fremstilling og farmaceutiske præparater deraf

Country Status (41)

Country Link
US (1) US5728849A (ro)
EP (1) EP0876362B1 (ro)
JP (1) JP3953106B2 (ro)
KR (1) KR100500351B1 (ro)
CN (1) CN1103766C (ro)
AR (1) AR005197A1 (ro)
AT (1) ATE250593T1 (ro)
AU (1) AU712597B2 (ro)
BG (1) BG63204B1 (ro)
BR (1) BR9612135A (ro)
CA (1) CA2238884C (ro)
CO (1) CO4520184A1 (ro)
CZ (1) CZ294972B6 (ro)
DE (1) DE69630145T2 (ro)
DK (1) DK0876362T3 (ro)
DZ (1) DZ2149A1 (ro)
EA (1) EA001533B1 (ro)
ES (1) ES2202490T3 (ro)
FR (1) FR2742751B1 (ro)
HK (1) HK1017895A1 (ro)
HU (1) HU225032B1 (ro)
IL (1) IL124994A (ro)
IN (4) IN186768B (ro)
MA (1) MA26412A1 (ro)
MX (1) MX9804688A (ro)
MY (1) MY113934A (ro)
NO (1) NO317358B1 (ro)
NZ (1) NZ324337A (ro)
OA (1) OA10700A (ro)
PE (1) PE25198A1 (ro)
PL (1) PL189311B1 (ro)
PT (1) PT876362E (ro)
RO (1) RO116194B1 (ro)
SK (1) SK282835B6 (ro)
TN (1) TNSN96169A1 (ro)
TR (1) TR199801179T2 (ro)
TW (1) TW371659B (ro)
UA (1) UA48205C2 (ro)
UY (1) UY24386A1 (ro)
WO (1) WO1997023473A1 (ro)
ZA (1) ZA9610737B (ro)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
JP2003522171A (ja) 2000-02-02 2003-07-22 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド 抗腫瘍剤としてのc10カーボネート置換タキサン
KR100926247B1 (ko) * 2001-02-24 2009-11-12 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 크산틴 유도체를 포함하는 약제학적 조성물 및 이의제조방법
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
CA2526278A1 (en) * 2003-05-20 2004-12-02 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising a liposomal platinum complex
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
EP1669358A1 (en) * 2004-12-07 2006-06-14 Aventis Pharma S.A. Cytotoxic agents comprising new taxanes
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
NZ573360A (en) 2006-05-04 2012-08-31 Boehringer Ingelheim Int Polymorphic forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
EP2190434B1 (en) * 2007-08-17 2019-04-17 Boehringer Ingelheim International GmbH Purin derivatives for use in the treatment of fap-related diseases
AR071175A1 (es) 2008-04-03 2010-06-02 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
KR20190016601A (ko) 2008-08-06 2019-02-18 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
JP5906086B2 (ja) * 2008-08-15 2016-04-20 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Fab関連疾患の治療に用いるためのプリン誘導体
JP2012502081A (ja) 2008-09-10 2012-01-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糖尿病及び関連症状の治療のための組み合わせ治療
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
TWI508965B (zh) 2008-12-23 2015-11-21 Boehringer Ingelheim Int 有機化合物的鹽形式
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
JP2013512229A (ja) 2009-11-27 2013-04-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 遺伝子型が同定された糖尿病患者のリナグリプチン等のddp−iv阻害薬による治療
NZ602921A (en) 2010-05-05 2016-01-29 Boehringer Ingelheim Int Combination therapy comprising the administration of a glp-1 receptor agonist and a ddp-4 inhibitor
MX2012014247A (es) 2010-06-24 2013-01-18 Boehringer Ingelheim Int Terapia para la diabetes.
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
EP3517539B1 (en) 2011-07-15 2022-12-14 Boehringer Ingelheim International GmbH Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
WO2013171167A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
CA2891280C (en) 2012-11-24 2018-03-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
FR3010839B1 (fr) * 2013-09-17 2017-04-21 Schneider Electric Ind Sas Dispositif de raccordement electrique d'au moins un conducteur dans une borne appartenant a un appareil electrique
PT3122757T (pt) 2014-02-28 2023-11-03 Hangzhou Dac Biotech Co Ltd Ligantes carregados e as suas utilizações em conjugação
US9526728B2 (en) 2014-02-28 2016-12-27 Boehringer Ingelheim International Gmbh Medical use of a DPP-4 inhibitor
EP3319936A4 (en) 2015-07-12 2019-02-06 Suzhou M-conj Biotech Co., Ltd. PLACES OF CONDUCT FOR THE CONJUGATION OF CELL BINDING MOLECULES
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
EP3468562A1 (en) 2016-06-10 2019-04-17 Boehringer Ingelheim International GmbH Combinations of linagliptin and metformin
JP7138350B2 (ja) 2016-11-14 2022-09-16 ハンジョウ ディーエーシー バイオテック シーオー.,エルティディ. 共役連結体、該連結体を含有する細胞結合分子-薬物共役体、並びに該共役体及び連結体の使用及び製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017724C1 (ru) * 1990-07-12 1994-08-15 Дзе Юниверсити оф Канзас Способ получения производных таксола
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
FR2678930B1 (fr) * 1991-07-10 1995-01-13 Rhone Poulenc Rorer Sa Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
RU2059631C1 (ru) * 1991-11-29 1996-05-10 Дзе Юниверсити оф Канзас Производные таксола и фармацевтическая композиция, обладающая противоопухолевой активностью
EP0639186B1 (en) * 1992-04-17 1999-06-23 Abbott Laboratories Taxol derivatives
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
IL107950A (en) * 1992-12-15 2001-04-30 Upjohn Co b 7, b 8 - Matano - Taxols, their preparation and pharmaceutical preparations against malignant tumors containing them

Also Published As

Publication number Publication date
WO1997023473A1 (fr) 1997-07-03
EA199800588A1 (ru) 1998-12-24
AU1180997A (en) 1997-07-17
IN186768B (ro) 2001-11-03
FR2742751B1 (fr) 1998-01-30
IN188469B (ro) 2002-09-28
TR199801179T2 (xx) 1998-10-21
EP0876362B1 (fr) 2003-09-24
CZ196198A3 (cs) 1998-09-16
OA10700A (fr) 2002-11-27
JP3953106B2 (ja) 2007-08-08
MA26412A1 (fr) 2004-12-20
TNSN96169A1 (fr) 2005-03-15
UA48205C2 (uk) 2002-08-15
HUP9904046A3 (en) 2001-08-28
IL124994A0 (en) 1999-01-26
MX9804688A (es) 1998-10-31
CN1103766C (zh) 2003-03-26
IN188470B (ro) 2002-09-28
AU712597B2 (en) 1999-11-11
DE69630145D1 (de) 2003-10-30
US5728849A (en) 1998-03-17
ZA9610737B (en) 1997-06-27
PL189311B1 (pl) 2005-07-29
NZ324337A (en) 2000-03-27
HK1017895A1 (en) 1999-12-03
CA2238884C (fr) 2007-02-06
ATE250593T1 (de) 2003-10-15
IL124994A (en) 2000-12-06
KR19990076680A (ko) 1999-10-15
CZ294972B6 (cs) 2005-04-13
PL327405A1 (en) 1998-12-07
MY113934A (en) 2002-06-29
AR005197A1 (es) 1999-04-14
SK282835B6 (sk) 2002-12-03
DZ2149A1 (fr) 2002-10-23
PT876362E (pt) 2004-02-27
CO4520184A1 (es) 1997-10-15
BG102569A (en) 1999-04-30
TW371659B (en) 1999-10-11
HU225032B1 (en) 2006-05-29
SK85398A3 (en) 1998-11-04
NO982580D0 (no) 1998-06-05
FR2742751A1 (fr) 1997-06-27
ES2202490T3 (es) 2004-04-01
CN1205697A (zh) 1999-01-20
EP0876362A1 (fr) 1998-11-11
KR100500351B1 (ko) 2005-12-21
NO317358B1 (no) 2004-10-18
PE25198A1 (es) 1998-05-10
IN188680B (ro) 2002-10-26
EA001533B1 (ru) 2001-04-23
JP2000502671A (ja) 2000-03-07
NO982580L (no) 1998-06-05
CA2238884A1 (fr) 1997-07-03
HUP9904046A1 (hu) 2001-04-28
BG63204B1 (bg) 2001-06-29
RO116194B1 (ro) 2000-11-30
DE69630145T2 (de) 2004-07-15
BR9612135A (pt) 1999-07-13
UY24386A1 (es) 2001-08-27

Similar Documents

Publication Publication Date Title
DK0817779T3 (da) Nye taxoider, deres fremstilling og farmaceutiske præparater deraf
DK0876362T3 (da) Nye taxoider, deres fremstilling og farmaceutiske præparater deraf
FI973039A0 (fi) Uusia farnesyylitransferaasin inhibiittoreita, niiden valmistus ja niitä sisältäviä farmaseuttisia koostumuksia
DK0820448T3 (da) Nye taxoider, deres fremstilling og farmaceutiske præparater deraf
IS1947B (is) Setin bensýlamínópíperidín efnasambönd og lyfjablöndur þeirra
NO996433L (no) Nye formuleringer av legemidler, fremgangsmåter for fremstilling derav og fremgangsmåter for anvendelse derav
NO20001409L (no) Karboksamidotiazolderivater, fremgangsmÕte for fremstilling derav og farmasøytiske blandinger
FI973279A (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
NO975710L (no) Nye Dolastatinderivater, deres fremstilling og anvendelse
NO961160L (no) Cykliske forbindelser, deres fremstilling og anvendelse
NO20024176L (no) Farmasöytiske preparater inneholder derivater av 3-amino- azetidin, de nye derivater og deres fremstilling
IS4706A (is) Lyfjasamsetningar
NO952677D0 (no) Nye dihydropyrrolopyridinon- og oksazolopyridinonforbindelser, deres fremstilling og farmasöytiske preparater
EE03680B1 (et) Asendatud püridiinid, nende kasutamine ja farmatseutilised kompositsioonid
IS1846B (is) Setin N-(indól-2-karbónýl)-b-alaninamíð, notkun þeirra og lyfjaefnablöndur
DE69300913D1 (de) Polymorph Terazosin und pharmazeutische Zusammenstellung.
DK1112266T3 (da) Substituerede 4-amino-2-arylpyrimidiner, fremstilling og anvendelse deraf og farmaceutiske præparater indeholdende dem
NO983472D0 (no) Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene
FI973229A0 (fi) Uusi farmaseuttinen koostumus
DK0821680T3 (da) Nye taxoider, fremstilling af disse forbindelser og farmaceutiske præparater indeholdende disse forbindelser
NO981195D0 (no) Nye aminoresin sammensetninger
NO974057D0 (no) Bisykliske takykinin-antagonister, fremstilling derav og deres anvendelse i farmasöytisk sammensetning
NO308842B1 (no) Nye retinoider, anvendelse derav, og farmasøytiske preparater inneholdende dem
NO973230D0 (no) Nye peptider, deres fremstilling og anvendelse